Table 2 Logistic regression of clinical pathological characteristics and ALDH2 expression.
Clinical Characteristics | Total (N) | OR | 95% CI | P value |
---|---|---|---|---|
Clinical stage | ||||
Ā Stage II vs. Stage I | 114 | 0.736 | 0.254ā1.996 | 0.555 |
Ā Stage III vs. Stage I | 121 | 0.519 | 0.180ā1.396 | 0.202 |
Ā Stage IV vs. Stage I | 291 | 0.566 | 0.205ā1.452 | 0.247 |
T stage | ||||
Ā T2 vs. T1 | 177 | 0.836 | 0.379ā1.793 | 0.649 |
Ā T3 vs. T1 | 164 | 0.485 | 0.218ā1.048 | 0.069 |
Ā T4 vs. T1 | 212 | 0.643 | 0.295ā1.358 | 0.253 |
N stage | ||||
Ā N1 vs. N0 | 319 | 0.881 | 0.530ā1.467 | 0.624 |
Ā N2 vs. N0 | 393 | 0.647 | 0.430ā0.971 | 0.036 |
Ā N3 vs. N0 | 246 | 0.133 | 0.007ā0.794 | 0.064 |
M stage | ||||
Ā M1 vs. M0 | 477 | 1.475 | 0.242ā11.273 | 0.672 |
Gender | ||||
Ā Male vs. Female | 502 | 0.850 | 0.571ā1.262 | 0.420 |
Age | ||||
Ā >ā65Ā vs. ā¤ā65 | 501 | 1.041 | 0.733ā1.478 | 0.822 |